drugset / Trial / NCT00092391
A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)
RandomizedSingle-groupDouble-blindPrevention
Summary
The purpose of this study is to determine the mumps virus strength at the end of shelf-life (expiration date) of an approved vaccine.
Timeline
- Start
- 1999-02
- Primary completion
- 2001-07
- Completion
- 2001-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | M-M-R(TM) II | Vaccine | 0.5 ml | Subcutaneous |
| Background | VARIVAX(TM) | Vaccine | 0.5 ml | Subcutaneous |